Clonal evolution in chronic myelogenous leukemia
- 30 June 2004
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 18 (3) , 671-684
- https://doi.org/10.1016/j.hoc.2004.03.012
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two casesCancer Genetics and Cytogenetics, 2003
- Chromosomal abnormalities in Philadelphia chromosome‐negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia in chronic phaseCancer, 2003
- Chromosomal abnormalities in Ph- cells of patients on imatinibBlood, 2003
- Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapyBlood, 2003
- Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylateLeukemia, 2003
- Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with ImatinibLeukemia, 2003
- The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CMLBlood, 2002
- Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of α-interferon therapy for Ph positive chronic myelocytic leukemiaCancer Genetics and Cytogenetics, 1995
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- Characteristics of accelerated disease in chronic myelogenous leukemiaCancer, 1988